Teva Identifies ‘Problem Pattern’ Of Complex CRLs Ahead Of GDUFA III
North America Head Brendan O’Grady Presses For Speedier Approvals
Teva says there are 12 complex products which it could debut in the US this year, but it won't get them all • Source: Shutterstock 
